|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.920 CAD | -2.73% |
|
-6.67% | -18.67% |
| 27/06 | HLS Therapeutics Inc. - Shareholder/Analyst Call | |
| 23/06 | HLS Therapeutics to Begin its Normal Course Issuer Bid | MT |
| Market Cap | 87.97M 76.16M 71.18M 65.06M 123M 8.39B 125M 835M 328M 4.2B 330M 323M 13.98B | P/E 2026 * |
-14.1x | P/E 2027 * | -93.8x |
|---|---|---|---|---|---|
| Enterprise Value | 87.97M 76.16M 71.18M 65.06M 123M 8.39B 125M 835M 328M 4.2B 330M 323M 13.98B | EV / Sales 2026 * |
1.52x | EV / Sales 2027 * | 1.37x |
| Free-Float |
99.47% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: HLS Therapeutics Inc.
| 1 day | -2.73% | ||
| 1 week | -6.67% | ||
| Current month | -6.67% | ||
| 1 month | -9.05% | ||
| 3 months | -16.42% | ||
| 6 months | -13.08% | ||
| Current year | -18.67% |
| 1 week | 3.92 |  | 4.29 |
| 1 month | 3.92 | | 4.3 |
| Current year | 3.92 | | 5.25 |
| 1 year | 3.92 | | 5.76 |
| 3 years | 3 | | 5.76 |
| 5 years | 3 | | 20.52 |
| 10 years | 3 | | 25.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Millian
CEO | Chief Executive Officer | 58 | 01/05/2023 |
John Hanna
DFI | Director of Finance/CFO | 61 | 26/01/2024 |
Jason Gross
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/06/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Rodney Hill
BRD | Director/Board Member | 58 | 12/03/2018 |
John Welborn
CHM | Chairman | 48 | 22/06/2023 |
Norma Beauchamp
BRD | Director/Board Member | 65 | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 26/6/26 | Option | Chief Technology Officer | 12,000 | 0.0384% | ||
| 26/6/26 | Option | Chief Financial Officer | 50,000 | 0.1599% | ||
| 16/6/26 | Buy | Chief Financial Officer | 4,000 | 0.0128% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.73% | -6.67% | -22.07% | -26.18% | 87.97M | |
| +1.18% | +6.37% | +31.60% | +102.74% | 103B | |
| +0.33% | +0.67% | +50.68% | +156.86% | 55.55B | |
| +0.34% | -0.34% | +3.50% | +270.00% | 24.05B | |
| +0.12% | -0.54% | -12.37% | -13.50% | 8.31B | |
| +2.21% | +3.71% | -30.23% | -25.33% | 7.7B | |
| -1.70% | -2.29% | -9.64% | -21.74% | 6.79B | |
| 0.00% | +3.07% | +19.28% | +14.99% | 6.19B | |
| 0.00% | -2.78% | -2.55% | +21.42% | 5.06B | |
| +1.20% | -1.94% | -5.61% | -5.78% | 3.73B | |
| Average | +0.22% | +0.49% | +2.26% | +47.35% | 22.01B | |
| Weighted average by Cap. | +0.68% | +3.24% | +26.46% | +115.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.03M 50.24M 46.96M 42.92M 80.87M 5.53B 82.13M 551M 216M 2.77B 218M 213M 9.22B | 64.31M 55.68M 52.04M 47.56M 89.63M 6.13B 91.03M 610M 239M 3.07B 241M 236M 10.22B |
| Net income | -6.26M -5.42M -5.07M -4.63M -8.73M -597M -8.87M -59.44M -23.32M -299M -23.52M -23.01M -995M | -1.05M -909K -850K -777K -1.46M -100M -1.49M -9.96M -3.91M -50.1M -3.94M -3.86M -167M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | CAD 3.920 | -2.73% | 13,375 |
| 07/08/26 | CAD 4.030 | +0.75% | 931 |
| 06/08/26 | CAD 4.000 | -2.91% | 4,774 |
| 05/08/26 | CAD 4.120 | 0.00% | 315 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HLS Stock
Select your edition
All financial news and data tailored to specific country editions
